Maricel Apuli
Chief Accounting Officer at Bridgebio Pharma · 11 reported transactions in 1 company · latest trade Jul 30, 2026
Their trades
Sold | Jul 30, 2026 | Jul 30, 2026 close $82.14 → Oct 26, 2026 close $68.15. S&P 500 +3.2% over the same days. | ||
Sold | Feb 26, 2026 | Feb 26, 2026 close $67.61 → Oct 26, 2026 close $68.15. S&P 500 +11.0% over the same days. | ||
Sold | Feb 17, 2026 | Feb 17, 2026 close $75.85 → Oct 26, 2026 close $68.15. S&P 500 +12.1% over the same days. | ||
Sold | Dec 8, 2025 | Dec 8, 2025 close $74.24 → Oct 26, 2026 close $68.15. S&P 500 +12.0% over the same days. |
SoldBridgebio Pharma
$160.1K
Jul 30, 2026 close $82.14 → Oct 26, 2026 close $68.15. S&P 500 +3.2% over the same days.
SoldBridgebio Pharma
$132K
Feb 26, 2026 close $67.61 → Oct 26, 2026 close $68.15. S&P 500 +11.0% over the same days.
SoldBridgebio Pharma
$37.9K
Feb 17, 2026 close $75.85 → Oct 26, 2026 close $68.15. S&P 500 +12.1% over the same days.
SoldBridgebio Pharma
$148.5K
Dec 8, 2025 close $74.24 → Oct 26, 2026 close $68.15. S&P 500 +12.0% over the same days.